Characterization of the role of Kunitz-type protease inhibitor domain in dimerization of amyloid precursor protein. 2023

Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
Department of Chemistry, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.

A major difference between amyloid precursor protein (APP) isoforms (APP695 and APP751) is the existence of a Kunitz type protease inhibitor (KPI) domain which has a significant impact on the homo- and hetero-dimerization of APP isoforms. However, the exact molecular mechanisms of dimer formation remain elusive. To characterize the role of the KPI domain in APP dimerization, we performed a single molecule pull down (SiMPull) assay where homo-dimerization between tethered APP molecules and soluble APP molecules was highly preferred regardless of the type of APP isoforms, while hetero-dimerization between tethered APP751 molecules and soluble APP695 molecules was limited. We further investigated the domain level APP-APP interactions using coarse-grained models with the Martini force field. Though the model initial ternary complexes (KPI-E1, KPI-KPI, KPI-E2, E1-E1, E2-E2, and E1-E2) generated using HADDOCK (HD) and AlphaFold2 (AF2), the binding free energy profiles and the binding affinities of the domain combinations were investigated via the umbrella sampling with Martini force field. Additionally, membrane-bound microenvironments at the domain level were modeled. As a result, it was revealed that the KPI domain has a stronger attractive interaction with itself than the E1 and E2 domains, as reported elsewhere. Thus, the KPI domain of APP751 may form additional attractive interactions with E1, E2 and the KPI domain itself, whereas it is absent in APP695. In conclusion, we found that the APP751 homo-dimer formation is predominant than the homodimerization in APP695, which is facilitated by the presence of the KPI domain.

UI MeSH Term Description Entries
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid
D019281 Dimerization The process by which two molecules of the same chemical composition form a condensation product or polymer. Dimerizations
D020033 Protein Isoforms Different forms of a protein that may be produced from different GENES, or from the same gene by ALTERNATIVE SPLICING. Isoform,Isoforms,Protein Isoform,Protein Splice Variant,Splice Variants, Protein,Protein Splice Variants,Isoform, Protein,Isoforms, Protein,Splice Variant, Protein,Variant, Protein Splice,Variants, Protein Splice

Related Publications

Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
February 1991, Gene,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
January 1994, FEBS letters,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
March 1990, Biochemical and biophysical research communications,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
July 1992, Biochemical and biophysical research communications,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
August 2013, Biochemical and biophysical research communications,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
December 1994, Biochimica et biophysica acta,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
January 1992, Journal of neuropathology and experimental neurology,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
January 2010, The Journal of biological chemistry,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
November 1996, The Journal of biological chemistry,
Jinyoung Byun, and Srivithya Vellampatti, and Prathit Chatterjee, and Sun Ha Hwang, and Byoung Choul Kim, and Juyong Lee
April 1991, Neuroscience letters,
Copied contents to your clipboard!